Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|1|75-85

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.1, 2015-07, pp. : 75-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bosentan for treatment of pulmonary arterial hypertension (I)

By Antoniu Sabina A  

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 843-847

Future Medicine

Access to resources Recommend Favorite

Bosentan for the treatment of pulmonary arterial hypertension (II)

By Antoniu Sabina A  

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 849-852

Future Medicine

Access to resources Recommend Favorite

Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension

By Souza Rogerio   Jardim Carlos   Martins Bárbara   Cortopassi Felipe   Yaksic Mateo   Rabelo Rogerio   Bogossian Humberto  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 907-912

Informa Healthcare

Access to resources Recommend Favorite

Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients

By Sasayama Shigetake   Satoh Toru   Izumi Tohru   Yoshida Shunji   Kyotani Shingo   Tahara Nobuhiro  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 395-400

Informa Healthcare

Access to resources Recommend Favorite

Sildenafil improves renal function in patients with pulmonary arterial hypertension

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 235-241

John Wiley & Sons Inc

Access to resources Recommend Favorite